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Edited by Gianni CesareniAbstract Using peptide aﬃnity puriﬁcation, we identiﬁed an
interaction between somatostatin receptors SSTR4 and SSTR1
and PDZ domains 1 and 2 of the postsynaptic proteins postsyn-
aptic density protein of 95 kDa (PSD-95) and PSD-93. The
existence of the SSTR4/PSD-95 complex was veriﬁed by coim-
munoprecipitation from transfected cells and solubilized brain
membranes. In neurons, dendritically localized SSTR4 partially
colocalizes with postsynaptic PSD-95. As functional parameters
of the receptor, such as coupling to potassium channels, are not
aﬀected by the interaction with PSD-95, the association may
serve to localize the receptor to postsynaptic sites.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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G-protein coupled receptors (GPCRs) interact with hetero-
trimeric G-proteins, thus enabling signal transduction across
the plasma membrane. GPCRs also interact with intracellular
scaﬀold proteins which are believed to either modify signaling
by the receptors, or target the receptors to speciﬁc subcellular
sites [1]. PDZ (PSD-95/discs large/ZO-1) domain proteins have
repeatedly been shown to bind to C-terminal peptide motifs of
GPCRs [2]. Approximately, 10% of all GPCRs carry C-termi-
nal PDZ binding motifs; in particular, all known receptors for
the neuropeptide somatostatin (SST; ﬁve receptor subtypes
termed SSTR1–5) carry such a motif. SSTRs preferentially
couple to Ptx-sensitive G-proteins and exhibit common intra-
cellular coupling patterns such as inhibition of adenylate cy-
clase [3] and activation of GIRK potassium channels [4].
However, distinct subcellular localizations were observed inAbbreviations: GPCR, G-protein coupled receptor; GST, glutathione
S-transferase; HEK, human embryonic kidney; PSD-95, postsynaptic
density protein of 95 kDa; SST, somatostatin; SSTR, somatostatin
receptor; ZO-1, zonula occludens 1
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doi:10.1016/j.febslet.2007.10.003brain and other tissues. SSTR1 was detected on axon terminals
of hypothalamic neurons [5], SSTR4 was found on neuronal
dendrites [6], and SSTR3 is localized to neuronal cilia [7].
Our systematic search for binding partners revealed interac-
tions with PDZ domain proteins SSTRIP/shank for SSTR2
[8], and PIST and PDZ-K1 for the SSTR5 [9]. Here we identify
PSD-95 as a binding partner for rat SSTR4 and provide evi-
dence that this interaction may serve to localize the receptor
to dendritic or postsynaptic compartments in neurons.2. Materials and methods
2.1. Fusion proteins and antibodies
A glutathione S-transferase (GST)-fusion protein containing the N-
terminal 40 residues of rat SSTR4 was used for generating a polyclonal
antiserum in rabbits (aSSTR4NT). An antiserum against the C-termi-
nus of the receptor (aSSTR4CT) was described before [6]. Monoclonal
anti-PSD-95 was obtained from Upstate/Millipore (Germany). GST-
fusion proteins of PSD-95 domains were expressed and puriﬁed as de-
scribed [10].
2.2. Peptide aﬃnity puriﬁcation
Synthetic peptides (Fig. 1A) were obtained from Genemed Synthesis
(San Francisco, CA). Peptides were coupled to NHS-activated Sephar-
ose (Amersham/GE Healthcare; Braunschweig, Germany) at a concen-
tration of 3 mg/ml sepharose matrix. The SSTR4-peptide was obtained
with an N-terminal cysteine for coupling to Sulfolink-beads (Pierce).
Aﬃnity puriﬁcation was performed as described [11], using mouse
brain membranes solubilized either in deoxycholate (DOC; 50 mM
NaF, 50 mM Tris–HCl, pH 9.0, 1% sodium deoxycholate, 5 mM
EDTA) buﬀer, or in 2% SDS, followed by 20-fold dilution into RIPA
buﬀer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% so-
dium deoxycholate, 5 mM EDTA, 0.1% SDS). Puriﬁed proteins were
analyzed by SDS-gel electrophoresis, followed by trypsin digestion
and tandem MS/MS sequencing of Coomassie stained bands.
2.3. Tissue culture
Human embryonic kidney cells (HEK 293) and hippocampal neu-
rons were cultivated as described [11]. For internalization assays,
HEK cells expressing T7-epitope tagged SSTR4 (with or without
PSD-95) were grown on cover slips; after treatment with 1 lM
SST14 for 30 min at 37 C in normal growth media, cells were ﬁxed,
permeabilized and stained for the receptor using the anti-T7 antibody
as described [15]. Cells were analyzed for the subcellular distribution of
the receptor using a confocal Zeiss LSM 410 microscope. For immuno-
cytochemistry of neurons, these were ﬁxed with 4% paraformaldehyde
in PBS after 14 days in culture and permeabilized with 0.3% Triton X-
100 in PBS for 5 min at room temperature. After blocking (2% normal
goat serum in PBS) for 1 h at room temperature cells were incubated
with aSSTR4CT antibody (diluted 1:1000 in blocking solution) and
anti-PSD-95 (1:25) for 2 h at room temperature, followed by 1 h ofblished by Elsevier B.V. All rights reserved.
Fig. 2. SSTR1 and SSTR4 bind to PDZ1 and PDZ2 of PSD-95. GST fusions of PSD-95 domains were prepared as indicated. Samples were split and
analyzed either directly (Input) or after precipitation with immobilized peptide by SDS–PAGE, followed by staining with Coomassie Brilliant Blue.
Molecular weights of marker (M) bands are indicated in kDa.
Fig. 1. Identiﬁcation of SSTR-interacting proteins from mouse brain. (A) Synthetic peptides used in this study. The canonical residues for PDZ type
I ligand motifs at the 1 position (hydrophobic) and the 3 position (Ser/Thr) are highlighted. (B) A mouse brain membrane fraction was lysed in
deoxycholate buﬀer; putative interacting proteins were precipitated from cleared supernatants using the peptide matrices indicated. Precipitates were
analyzed by SDS–PAGE, followed by staining with Coomassie Brilliant Blue. (C) Membranes were lyzed in 2 % SDS, followed by 20-fold dilution
into RIPA buﬀer. Precipitation using the peptide matrices indicated was performed and analyzed as in B.
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luted 1:600 in blocking solution). Immunostaining was again visualized
by confocal microscopy.
2.4. Immunoprecipitation
HEK cells transfected with T7-epitope tagged SSTR4 and PSD-95
constructs were lysed in RIPA buﬀer. Lysates were cleared by centrifu-
gation (15 min; 20000 · g) and the NT7-SSTR4 receptor was precipi-
tated by incubation with anti-T7 agarose. After washing, precipitated
complexes were analysed by Western blotting. For precipitation from
rat brain, a P2 (postnuclear) membrane fraction was lysed in n-dode-
cyl-maltosid (4 mg/ml) containing buﬀer (150 mMNaCl; 5 mMEDTA,
3 mMEGTA; 20 mMHEPES, pH7.4; including protease inhibitors) for
1 h at 4 C. Insoluble proteins were removed by centrifugation (20000 ·
g, 30 min) and the supernatant was incubated with wheat germ aggluti-
nin (WGA)-agarose. Proteins were eluted with N-acetylglucosamine.
aSSTR4NT and a non-related control antibody were immobilized on
NHS-sepharose and used for immunoprecipitation from the WGA-elu-
ate in lysis buﬀer. Precipitates were analyzed by Western Blotting.
2.5. Expression in Xenopus oocytes
The cDNA coding for rat PSD-95 was subcloned into pGEMHE;
rSSTR4 and GIRK1 cDNAs were in pcDNA3, as described [4]. Plas-
mids were linearized, and capped cRNAs were transcribed using T7
RNA polymerase (Fermentas, Vilnius, Lithuania). Injection into oo-
cytes and voltage clamp measurements were performed as described
previously [4]. Data were ﬁtted by non-linear regression using Graph-
Pad Prism (GraphPad Inc., San Diego, CA).Fig. 3. Interaction of SSTR4 and PSD-95 in cells. (A) Coimmuno-
preciptation from HEK cells. HEK cells were transfected with the
plasmids indicated. After lysis in RIPA buﬀer, the SSTR4 was
precipitated using anti-T7-agarose directed against the N-terminal
T7-epitope. Input (in) and precipitates (prec) were analyzed by
Western blotting using anti-EGFP. (B) Coimmunoprecipitation from
rat brain lysate. After lysis of a rat brain membranes in dodecyl-
maltoside, glycoproteins were enriched by WGA chromatography (left
lane). From this fraction, immunoprecipitation was performed using
either anti-SSTR4NT (middle lane) or control antiserum (right). WGA
fraction and precipitates were analyzed by Western Blotting using anti-
PSD-95.3. Results
3.1. Identiﬁcation of SSTR-interacting proteins
In order to identify binding partners for SSTRs which are
expressed strongly in brain, immobilized carboxyterminal pep-
tides of receptors SSTR1–4 (and other control proteins, see be-
low) were used as aﬃnity matrices for the puriﬁcation of
interacting proteins. Puriﬁcation was performed in deoxycho-
late (DOC) buﬀer with the intention to leave receptor-associ-
ated complexes intact, allowing for secondary interactions of
putative interacting proteins [12]. Two major bands at 90–
100 kDa were obtained in the case of SSTR1 and SSTR4, with
additional bands at 48 kDa and higher molecular weights
(Fig. 1B). Some diﬀuse bands in the 50–60 kDa range were
considered to be non-speciﬁc as they appeared in all samples.
The main SSTR4 and SSTR1 associated bands were identiﬁed
as PSD-95 and PSD-93. In order to test for a direct interaction
with the C-terminus of SSTR4, we repeated the puriﬁcation,
but performed the initial solubilization in 2% SDS, followed
by dilution into RIPA buﬀer. Under these conditions, all inter-
actions within the membrane preparation should be disrupted,
so that only proteins binding directly to the peptide matrix
should be present in the puriﬁed sample (see [11]). The C-ter-
mini of GKAP and the NMDA-receptor 2B-subunit were used
as further controls. Here, only the main bands at 95 and
100 kDa were precipitated by the SSTR4 matrix as well as
by the NMDAR2B-matrix but not by the GKAP peptide
(Fig. 1C), conﬁrming that both proteins interact speciﬁcally
and directly with the rSSTR4 C-terminus (and the
NMDAR2B-subunit [13]).
To identify which PDZ domain of PSD-95 mediates the
interaction, the peptide matrices were used to pull down indi-
vidual domains expressed in bacteria as GST fusion proteins.
Here the guanylate cyclase C-terminus (interacting with
PDZ3; [14]) was included, together with an additional negative
control derived from the TRH receptor C-terminus. Thisexperiment clearly showed that both SSTR1 and SSTR4 C-ter-
minal peptides interact most eﬃciently with PDZ2 and to a les-
ser degree PDZ1, similar to the NMDAR2B C-terminus
(Fig. 2). The guanylate cyclase peptide prefers PDZ3 over
PDZ2, and does not bind PDZ1 at all, as described [14].
Whereas neither TRH-R, SSTR3 or GKAP derived peptides
interact with any of the domains tested, the SSTR2 peptide
binds with low eﬃciency to the second PDZ domain. However,
SSTR2 does not bind to recombinant full-length PSD-95, or
the native protein from brain lysates (Figs. 2 and 1B).
3.2. Interaction of SSTR4 and PSD-95 in cells
To verify interaction between SSTR4 and PSD-95 in a cellu-
lar system, we expressed PSD-95 and SSTR4 in HEK293 cells.
After cell lysis, the receptor was immunoprecipiated via its N-
terminal T7-epitope tag. PSD-95 could be readily detected in
lysates, and was also found in the precipitate from cells coex-
pressing the receptor, but not from cells expressing PSD-95
alone (Fig. 3A). These data conﬁrmed that SSTR4 and PSD-
95 can form a complex in a cellular environment.
To show an association between both proteins in their native
environment we tried to coimmunoprecipitate SSTR4 and
PSD-95 from solubilized rodent brain material. For this pur-
pose we developed an antibody against the SSTR4 N-termi-
nus. In previous experiments detection of SSTR4 by Western
blotting was diﬃcult due to the low abundance of the receptor
Fig. 4. Colocalization in cultivated hippocampal neurons. (A) Western Blot of hippocampal neurons at diﬀerent developmental stages. Lysates were
prepared in RIPA buﬀer and analyzed by Western blotting using the antibodies indicated. (B) Immunocytochemistry. Neurons cultivated for 14 days
in vitro were ﬁxed and stained for SSTR4 (left, red signal) and PSD-95 (middle, green signal). The right pictures show the merged images, with yellow
staining indicating colocalization. The lower panel shows a magniﬁcation of the region indicated in the merged picture. Bar, 5 lm.
Table 1
Functional characteristics of SSTR4 measured in the absence and presence of PSD-95
Expression EC50 for SST14 (nM) Time constant (min1) Internalization
SSTR4  PSD-95 113 ± 43 0.1024 ± 0.058 No
SSTR4 + PSD-95 92 ± 39 0.1032 ± 0.044 No
SSTR4 and GIRK1 channel were coexpressed with of without PSD-95 in Xenopus oocytes; EC50 values and current decay after agonist washout
were determined as described in [15]. Agonist dependent internalization was determined in HEK cells expressing SSTR4 with or without PSD-95 and
treated with 1 lM SST14 for 30 min before ﬁxation. Cells were scored for the occurrence of intracellular SSTR4 containing vesicles by immuno-
ﬂuorescence analysis [15].
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cyl-maltoside and enriched the preparation for glycosylated
proteins via a WGA-matrix as described [6]. After elution with
N-acetylglucosamin, SSTR4 was immunoprecipitated from the
eluate using the N-terminal antibody. Whereas only very little
of the total PSD-95 was present in the n-dodecyl-maltoside sol-
ubilized/WGA-enriched fractions (Fig. 3B) the protein was
very eﬃciently coprecipitated with the SSTR4 N-terminal anti-body in the following step, clearly indicating that PSD-95 in-
deed interacts with the SSTR4 in vivo.
The cellular location of both proteins was analyzed in cul-
tured hippocampal neurons. Both proteins are not expressed
at early stages after plating, but expression was readily detect-
able at 7 and 14 days after plating (Fig. 4A). Immunohisto-
chemistry using aﬃnity-puriﬁed anti-SSTR4 showed that the
receptor is present in many but not all dendritic processes
M. Christenn et al. / FEBS Letters 581 (2007) 5173–5177 5177(Fig. 4B). Costaining with anti-PSD-95 indicated a partial
colocalization of both proteins. Whereas PSD-95 was clearly
enriched in brightly ﬂuorescent clusters which presumably rep-
resent postsynaptic sites, SSTR4 was distributed more homo-
geneously along the dendrite, with overlap observed only
within the PSD-95 clusters. These data indicate that only part
of the neuronal SSTR4 protein may be associated with PSD-95
in cultivated neurons.
The rat SSTR4 displays some particular features when com-
pared to other GPCRs; most notably, the intracellular signal
elicited by activation of this receptor decays very slowly [15].
In addition, SSTR4 is not subject to agonist induced endocy-
tosis [6,15]. Coexpression of SSTR4 and PSD-95 in either
Xenopus oocytes or HEK cells did alter neither of these prop-
erties (Table 1), suggesting that the SSTR4/PSD-95 interaction
is primarily involved in subcellular (in particular postsynaptic)
targeting of the receptor.4. Discussion
Our data demonstrate a direct interaction of the SSTR4 with
PDZ2 of the synaptic scaﬀolding protein, PSD-95. The C-ter-
minal sequences analyzed here, though sharing a PDZ ligand
motif, display considerable variation in the key residues of
the PDZ binding motif (especially the hydrophobic residue in
the 1 position) as well as in the 2 and 4 residues which
are believed to impart speciﬁcity (Fig. 1). Thus it is diﬃcult
to predict aﬃnity for a particular PDZ domain based on se-
quence alone [16]. PDZ domains of PSD-95 exhibit a remark-
able promiscuity, as they can accommodate quite a variety of
C-terminal ligands [17]. In this respect the peptide pulldown
technique employed here and in previous studies [11,12] repre-
sents a fast and straightforward way to identify high aﬃnity
ligands in a competitive situation.
The interaction between SSTR4 and PSD-95 does not aﬀect
signalling of the receptor in recombinant systems (oocytes and
HEK cells). Thus we favour a role of this interaction in target-
ing SSTR4 to postsynaptic sites; indeed an immunocytochem-
ical study of the rat brain demonstrated that the SSTR4 is
present in the somatodendritic domain. In particular, immuno-
reactivity for the receptor was also found postsynaptically at
asymmetric synapses [6], and this is the location where the
receptor might be anchored by PSD-95. Interestingly, several
studies have indicated that SSTR4 potentiates AMPA-receptor
mediated excitatory signalling [18,19], in contrast to its well-
documented coupling to inhibitory G-proteins. As AMPA
receptors are also attached to PSD-95 (via the accessory pro-
tein stargazin), the close proximity of these diﬀerent receptor
systems might determine the result of SSTR4 signalling in
the hippocampus.
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